The global Parkinson’s Disease Therapeutics market is projected to grow from US$ 2489.7 million in 2024 to US$ 3533.7 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.0% during the forecast period.

Parkinson’s Disease Therapeutics Market

Parkinson's disease therapeutics includes medications and therapies used to manage the symptoms of Parkinson's disease, a neurodegenerative disorder that affects movement and motor control.

Market Analysis and Insights: Global Parkinson’s Disease Therapeutics Market

The market for Parkinson's disease therapeutics is driven by the increasing prevalence of Parkinson's disease and the demand for symptomatic relief and disease-modifying treatments. The market's growth is also influenced by ongoing research in Parkinson's disease pathophysiology and the development of novel therapeutic approaches.

Report Covers:

This report presents an overview of global market for Parkinson’s Disease Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Parkinson’s Disease Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Parkinson’s Disease Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Parkinson’s Disease Therapeutics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Parkinson’s Disease Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Parkinson’s Disease Therapeutics revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Parkinson’s Disease Therapeutics Market Report

Report Metric	Details
Report Name	Parkinson’s Disease Therapeutics Market
Accounted market size in 2024	US$ 2489.7 million
Forecasted market size in 2030	US$ 3533.7 million
CAGR	6.0
Base Year	2024
Forecasted years	2024 - 2030
Segment by Type	Oral Transdermal Subcutaneous Intestinal Infusion
Segment by Application	Hospitals Clinics Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbvie, Biogen, Boehringer Ingelheim GmbH, F. Hoffman-La Roche, GlaxoSmithKline, H. Lundbeck A/S, Impax Labs, Newron Pharmaceuticals SpA, Novartis AG, Orion Corporation, Teva Pharmaceutical Industries Ltd., UCB S.A., Livzon Pharmaceutical, Haisco Pharmaceutical, Jingxin Pharmaceutical, Dongcheng Biochemicals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Parkinson’s Disease Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Parkinson’s Disease Therapeutics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Parkinson’s Disease Therapeutics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Parkinson’s Disease Therapeutics Market growing?

Ans: The Parkinson’s Disease Therapeutics Market witnessing a CAGR of 6.0 during the forecast period 2024-2030.

What is the Parkinson’s Disease Therapeutics Market size in 2030?

Ans: The Parkinson’s Disease Therapeutics Market size in 2030 will be US$ 3533.7 million.

Who are the main players in the Parkinson’s Disease Therapeutics Market report?

Ans: The main players in the Parkinson’s Disease Therapeutics Market are Abbvie, Biogen, Boehringer Ingelheim GmbH, F. Hoffman-La Roche, GlaxoSmithKline, H. Lundbeck A/S, Impax Labs, Newron Pharmaceuticals SpA, Novartis AG, Orion Corporation, Teva Pharmaceutical Industries Ltd., UCB S.A., Livzon Pharmaceutical, Haisco Pharmaceutical, Jingxin Pharmaceutical, Dongcheng Biochemicals

What are the Application segmentation covered in the Parkinson’s Disease Therapeutics Market report?

Ans: The Applications covered in the Parkinson’s Disease Therapeutics Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Parkinson’s Disease Therapeutics Market report?

Ans: The Types covered in the Parkinson’s Disease Therapeutics Market report are Oral, Transdermal, Subcutaneous, Intestinal Infusion

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Parkinson’s Disease Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Oral

1.2.3 Transdermal

1.2.4 Subcutaneous

1.2.5 Intestinal Infusion

1.3 Market by Application

1.3.1 Global Parkinson’s Disease Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Parkinson’s Disease Therapeutics Market Perspective (2019-2030)

2.2 Global Parkinson’s Disease Therapeutics Growth Trends by Region

2.2.1 Parkinson’s Disease Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Parkinson’s Disease Therapeutics Historic Market Size by Region (2019-2024)

2.2.3 Parkinson’s Disease Therapeutics Forecasted Market Size by Region (2025-2030)

2.3 Parkinson’s Disease Therapeutics Market Dynamics

2.3.1 Parkinson’s Disease Therapeutics Industry Trends

2.3.2 Parkinson’s Disease Therapeutics Market Drivers

2.3.3 Parkinson’s Disease Therapeutics Market Challenges

2.3.4 Parkinson’s Disease Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Parkinson’s Disease Therapeutics by Players

3.1.1 Global Parkinson’s Disease Therapeutics Revenue by Players (2019-2024)

3.1.2 Global Parkinson’s Disease Therapeutics Revenue Market Share by Players (2019-2024)

3.2 Global Parkinson’s Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Parkinson’s Disease Therapeutics, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Parkinson’s Disease Therapeutics Market Concentration Ratio

3.4.1 Global Parkinson’s Disease Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Parkinson’s Disease Therapeutics Revenue in 2023

3.5 Global Key Players of Parkinson’s Disease Therapeutics Head office and Area Served

3.6 Global Key Players of Parkinson’s Disease Therapeutics, Product and Application

3.7 Global Key Players of Parkinson’s Disease Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Parkinson’s Disease Therapeutics Breakdown Data by Type

4.1 Global Parkinson’s Disease Therapeutics Historic Market Size by Type (2019-2024)

4.2 Global Parkinson’s Disease Therapeutics Forecasted Market Size by Type (2025-2030)

5 Parkinson’s Disease Therapeutics Breakdown Data by Application

5.1 Global Parkinson’s Disease Therapeutics Historic Market Size by Application (2019-2024)

5.2 Global Parkinson’s Disease Therapeutics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Parkinson’s Disease Therapeutics Market Size (2019-2030)

6.2 North America Parkinson’s Disease Therapeutics Market Size by Type

6.2.1 North America Parkinson’s Disease Therapeutics Market Size by Type (2019-2024)

6.2.2 North America Parkinson’s Disease Therapeutics Market Size by Type (2025-2030)

6.2.3 North America Parkinson’s Disease Therapeutics Market Share by Type (2019-2030)

6.3 North America Parkinson’s Disease Therapeutics Market Size by Application

6.3.1 North America Parkinson’s Disease Therapeutics Market Size by Application (2019-2024)

6.3.2 North America Parkinson’s Disease Therapeutics Market Size by Application (2025-2030)

6.3.3 North America Parkinson’s Disease Therapeutics Market Share by Application (2019-2030)

6.4 North America Parkinson’s Disease Therapeutics Market Size by Country

6.4.1 North America Parkinson’s Disease Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Parkinson’s Disease Therapeutics Market Size by Country (2019-2024)

6.4.3 North America Parkinson’s Disease Therapeutics Market Size by Country (2025-2030)

6.4.4 United States

6.4.5 Canada

7 Europe

7.1 Europe Parkinson’s Disease Therapeutics Market Size (2019-2030)

7.2 Europe Parkinson’s Disease Therapeutics Market Size by Type

7.2.1 Europe Parkinson’s Disease Therapeutics Market Size by Type (2019-2024)

7.2.2 Europe Parkinson’s Disease Therapeutics Market Size by Type (2025-2030)

7.2.3 Europe Parkinson’s Disease Therapeutics Market Share by Type (2019-2030)

7.3 Europe Parkinson’s Disease Therapeutics Market Size by Application

7.3.1 Europe Parkinson’s Disease Therapeutics Market Size by Application (2019-2024)

7.3.2 Europe Parkinson’s Disease Therapeutics Market Size by Application (2025-2030)

7.3.3 Europe Parkinson’s Disease Therapeutics Market Share by Application (2019-2030)

7.4 Europe Parkinson’s Disease Therapeutics Market Size by Country

7.4.1 Europe Parkinson’s Disease Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Parkinson’s Disease Therapeutics Market Size by Country (2019-2024)

7.4.3 Europe Parkinson’s Disease Therapeutics Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Parkinson’s Disease Therapeutics Market Size (2019-2030)

8.2 China Parkinson’s Disease Therapeutics Market Size by Type

8.2.1 China Parkinson’s Disease Therapeutics Market Size by Type (2019-2024)

8.2.2 China Parkinson’s Disease Therapeutics Market Size by Type (2025-2030)

8.2.3 China Parkinson’s Disease Therapeutics Market Share by Type (2019-2030)

8.3 China Parkinson’s Disease Therapeutics Market Size by Application

8.3.1 China Parkinson’s Disease Therapeutics Market Size by Application (2019-2024)

8.3.2 China Parkinson’s Disease Therapeutics Market Size by Application (2025-2030)

8.3.3 China Parkinson’s Disease Therapeutics Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Parkinson’s Disease Therapeutics Market Size (2019-2030)

9.2 Asia Parkinson’s Disease Therapeutics Market Size by Type

9.2.1 Asia Parkinson’s Disease Therapeutics Market Size by Type (2019-2024)

9.2.2 Asia Parkinson’s Disease Therapeutics Market Size by Type (2025-2030)

9.2.3 Asia Parkinson’s Disease Therapeutics Market Share by Type (2019-2030)

9.3 Asia Parkinson’s Disease Therapeutics Market Size by Application

9.3.1 Asia Parkinson’s Disease Therapeutics Market Size by Application (2019-2024)

9.3.2 Asia Parkinson’s Disease Therapeutics Market Size by Application (2025-2030)

9.3.3 Asia Parkinson’s Disease Therapeutics Market Share by Application (2019-2030)

9.4 Asia Parkinson’s Disease Therapeutics Market Size by Region

9.4.1 Asia Parkinson’s Disease Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Parkinson’s Disease Therapeutics Market Size by Region (2019-2024)

9.4.3 Asia Parkinson’s Disease Therapeutics Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Parkinson’s Disease Therapeutics Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Parkinson’s Disease Therapeutics Market Size by Type

10.2.1 Middle East, Africa, and Latin America Parkinson’s Disease Therapeutics Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Parkinson’s Disease Therapeutics Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Parkinson’s Disease Therapeutics Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Parkinson’s Disease Therapeutics Market Size by Application

10.3.1 Middle East, Africa, and Latin America Parkinson’s Disease Therapeutics Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Parkinson’s Disease Therapeutics Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Parkinson’s Disease Therapeutics Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Parkinson’s Disease Therapeutics Market Size by Country

10.4.1 Middle East, Africa, and Latin America Parkinson’s Disease Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Parkinson’s Disease Therapeutics Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Parkinson’s Disease Therapeutics Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Abbvie

11.1.1 Abbvie Company Details

11.1.2 Abbvie Business Overview

11.1.3 Abbvie Parkinson’s Disease Therapeutics Introduction

11.1.4 Abbvie Revenue in Parkinson’s Disease Therapeutics Business (2019-2024)

11.1.5 Abbvie Recent Developments

11.2 Biogen

11.2.1 Biogen Company Details

11.2.2 Biogen Business Overview

11.2.3 Biogen Parkinson’s Disease Therapeutics Introduction

11.2.4 Biogen Revenue in Parkinson’s Disease Therapeutics Business (2019-2024)

11.2.5 Biogen Recent Developments

11.3 Boehringer Ingelheim GmbH

11.3.1 Boehringer Ingelheim GmbH Company Details

11.3.2 Boehringer Ingelheim GmbH Business Overview

11.3.3 Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Introduction

11.3.4 Boehringer Ingelheim GmbH Revenue in Parkinson’s Disease Therapeutics Business (2019-2024)

11.3.5 Boehringer Ingelheim GmbH Recent Developments

11.4 F. Hoffman-La Roche

11.4.1 F. Hoffman-La Roche Company Details

11.4.2 F. Hoffman-La Roche Business Overview

11.4.3 F. Hoffman-La Roche Parkinson’s Disease Therapeutics Introduction

11.4.4 F. Hoffman-La Roche Revenue in Parkinson’s Disease Therapeutics Business (2019-2024)

11.4.5 F. Hoffman-La Roche Recent Developments

11.5 GlaxoSmithKline

11.5.1 GlaxoSmithKline Company Details

11.5.2 GlaxoSmithKline Business Overview

11.5.3 GlaxoSmithKline Parkinson’s Disease Therapeutics Introduction

11.5.4 GlaxoSmithKline Revenue in Parkinson’s Disease Therapeutics Business (2019-2024)

11.5.5 GlaxoSmithKline Recent Developments

11.6 H. Lundbeck A/S

11.6.1 H. Lundbeck A/S Company Details

11.6.2 H. Lundbeck A/S Business Overview

11.6.3 H. Lundbeck A/S Parkinson’s Disease Therapeutics Introduction

11.6.4 H. Lundbeck A/S Revenue in Parkinson’s Disease Therapeutics Business (2019-2024)

11.6.5 H. Lundbeck A/S Recent Developments

11.7 Impax Labs

11.7.1 Impax Labs Company Details

11.7.2 Impax Labs Business Overview

11.7.3 Impax Labs Parkinson’s Disease Therapeutics Introduction

11.7.4 Impax Labs Revenue in Parkinson’s Disease Therapeutics Business (2019-2024)

11.7.5 Impax Labs Recent Developments

11.8 Newron Pharmaceuticals SpA

11.8.1 Newron Pharmaceuticals SpA Company Details

11.8.2 Newron Pharmaceuticals SpA Business Overview

11.8.3 Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Introduction

11.8.4 Newron Pharmaceuticals SpA Revenue in Parkinson’s Disease Therapeutics Business (2019-2024)

11.8.5 Newron Pharmaceuticals SpA Recent Developments

11.9 Novartis AG

11.9.1 Novartis AG Company Details

11.9.2 Novartis AG Business Overview

11.9.3 Novartis AG Parkinson’s Disease Therapeutics Introduction

11.9.4 Novartis AG Revenue in Parkinson’s Disease Therapeutics Business (2019-2024)

11.9.5 Novartis AG Recent Developments

11.10 Orion Corporation

11.10.1 Orion Corporation Company Details

11.10.2 Orion Corporation Business Overview

11.10.3 Orion Corporation Parkinson’s Disease Therapeutics Introduction

11.10.4 Orion Corporation Revenue in Parkinson’s Disease Therapeutics Business (2019-2024)

11.10.5 Orion Corporation Recent Developments

11.11 Teva Pharmaceutical Industries Ltd.

11.11.1 Teva Pharmaceutical Industries Ltd. Company Details

11.11.2 Teva Pharmaceutical Industries Ltd. Business Overview

11.11.3 Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Introduction

11.11.4 Teva Pharmaceutical Industries Ltd. Revenue in Parkinson’s Disease Therapeutics Business (2019-2024)

11.11.5 Teva Pharmaceutical Industries Ltd. Recent Developments

11.12 UCB S.A.

11.12.1 UCB S.A. Company Details

11.12.2 UCB S.A. Business Overview

11.12.3 UCB S.A. Parkinson’s Disease Therapeutics Introduction

11.12.4 UCB S.A. Revenue in Parkinson’s Disease Therapeutics Business (2019-2024)

11.12.5 UCB S.A. Recent Developments

11.13 Livzon Pharmaceutical

11.13.1 Livzon Pharmaceutical Company Details

11.13.2 Livzon Pharmaceutical Business Overview

11.13.3 Livzon Pharmaceutical Parkinson’s Disease Therapeutics Introduction

11.13.4 Livzon Pharmaceutical Revenue in Parkinson’s Disease Therapeutics Business (2019-2024)

11.13.5 Livzon Pharmaceutical Recent Developments

11.14 Haisco Pharmaceutical

11.14.1 Haisco Pharmaceutical Company Details

11.14.2 Haisco Pharmaceutical Business Overview

11.14.3 Haisco Pharmaceutical Parkinson’s Disease Therapeutics Introduction

11.14.4 Haisco Pharmaceutical Revenue in Parkinson’s Disease Therapeutics Business (2019-2024)

11.14.5 Haisco Pharmaceutical Recent Developments

11.15 Jingxin Pharmaceutical

11.15.1 Jingxin Pharmaceutical Company Details

11.15.2 Jingxin Pharmaceutical Business Overview

11.15.3 Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Introduction

11.15.4 Jingxin Pharmaceutical Revenue in Parkinson’s Disease Therapeutics Business (2019-2024)

11.15.5 Jingxin Pharmaceutical Recent Developments

11.16 Dongcheng Biochemicals

11.16.1 Dongcheng Biochemicals Company Details

11.16.2 Dongcheng Biochemicals Business Overview

11.16.3 Dongcheng Biochemicals Parkinson’s Disease Therapeutics Introduction

11.16.4 Dongcheng Biochemicals Revenue in Parkinson’s Disease Therapeutics Business (2019-2024)

11.16.5 Dongcheng Biochemicals Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

AbbVie

Novartis

Biogen

Boehringer Ingelheim GmbH

Newron Pharmaceuticals SpA

Orion Corporation

Teva Pharmaceutical Industries Ltd

UCB

Livzon Pharmaceutical

Haisco Pharmaceutical

JINGXIN PHARMACEUTICAL

Dongcheng Biochemicals

List of Tables

Table 1. Global Parkinson’s Disease Therapeutics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Oral

Table 3. Key Players of Transdermal

Table 4. Key Players of Subcutaneous

Table 5. Key Players of Intestinal Infusion

Table 6. Global Parkinson’s Disease Therapeutics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 7. Global Parkinson’s Disease Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Parkinson’s Disease Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Parkinson’s Disease Therapeutics Market Share by Region (2019-2024)

Table 10. Global Parkinson’s Disease Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Parkinson’s Disease Therapeutics Market Share by Region (2025-2030)

Table 12. Parkinson’s Disease Therapeutics Market Trends

Table 13. Parkinson’s Disease Therapeutics Market Drivers

Table 14. Parkinson’s Disease Therapeutics Market Challenges

Table 15. Parkinson’s Disease Therapeutics Market Restraints

Table 16. Global Parkinson’s Disease Therapeutics Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Parkinson’s Disease Therapeutics Revenue Share by Players (2019-2024)

Table 18. Global Top Parkinson’s Disease Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson’s Disease Therapeutics as of 2023)

Table 19. Global Parkinson’s Disease Therapeutics Industry Ranking 2022 VS 2023 VS 2024

Table 20. Global 5 Largest Players Market Share by Parkinson’s Disease Therapeutics Revenue (CR5 and HHI) & (2019-2024)

Table 21. Global Key Players of Parkinson’s Disease Therapeutics, Headquarters and Area Served

Table 22. Global Key Players of Parkinson’s Disease Therapeutics, Product and Application

Table 23. Global Key Players of Parkinson’s Disease Therapeutics, Product and Application

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Parkinson’s Disease Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Parkinson’s Disease Therapeutics Revenue Market Share by Type (2019-2024)

Table 27. Global Parkinson’s Disease Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Parkinson’s Disease Therapeutics Revenue Market Share by Type (2025-2030)

Table 29. Global Parkinson’s Disease Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Parkinson’s Disease Therapeutics Revenue Share by Application (2019-2024)

Table 31. Global Parkinson’s Disease Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Parkinson’s Disease Therapeutics Revenue Share by Application (2025-2030)

Table 33. North America Parkinson’s Disease Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 34. North America Parkinson’s Disease Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 35. North America Parkinson’s Disease Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 36. North America Parkinson’s Disease Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 37. North America Parkinson’s Disease Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. North America Parkinson’s Disease Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 39. North America Parkinson’s Disease Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 40. Europe Parkinson’s Disease Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 41. Europe Parkinson’s Disease Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 42. Europe Parkinson’s Disease Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 43. Europe Parkinson’s Disease Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 44. Europe Parkinson’s Disease Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Europe Parkinson’s Disease Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 46. Europe Parkinson’s Disease Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 47. China Parkinson’s Disease Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 48. China Parkinson’s Disease Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 49. China Parkinson’s Disease Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 50. China Parkinson’s Disease Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 51. Asia Parkinson’s Disease Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 52. Asia Parkinson’s Disease Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 53. Asia Parkinson’s Disease Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 54. Asia Parkinson’s Disease Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 55. Asia Parkinson’s Disease Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 56. Asia Parkinson’s Disease Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 57. Asia Parkinson’s Disease Therapeutics Market Size by Region (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Parkinson’s Disease Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Parkinson’s Disease Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Parkinson’s Disease Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Parkinson’s Disease Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Parkinson’s Disease Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 63. Middle East, Africa, and Latin America Parkinson’s Disease Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 64. Middle East, Africa, and Latin America Parkinson’s Disease Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 65. Abbvie Company Details

Table 66. Abbvie Business Overview

Table 67. Abbvie Parkinson’s Disease Therapeutics Product

Table 68. Abbvie Revenue in Parkinson’s Disease Therapeutics Business (2019-2024) & (US$ Million)

Table 69. Abbvie Recent Developments

Table 70. Biogen Company Details

Table 71. Biogen Business Overview

Table 72. Biogen Parkinson’s Disease Therapeutics Product

Table 73. Biogen Revenue in Parkinson’s Disease Therapeutics Business (2019-2024) & (US$ Million)

Table 74. Biogen Recent Developments

Table 75. Boehringer Ingelheim GmbH Company Details

Table 76. Boehringer Ingelheim GmbH Business Overview

Table 77. Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Product

Table 78. Boehringer Ingelheim GmbH Revenue in Parkinson’s Disease Therapeutics Business (2019-2024) & (US$ Million)

Table 79. Boehringer Ingelheim GmbH Recent Developments

Table 80. F. Hoffman-La Roche Company Details

Table 81. F. Hoffman-La Roche Business Overview

Table 82. F. Hoffman-La Roche Parkinson’s Disease Therapeutics Product

Table 83. F. Hoffman-La Roche Revenue in Parkinson’s Disease Therapeutics Business (2019-2024) & (US$ Million)

Table 84. F. Hoffman-La Roche Recent Developments

Table 85. GlaxoSmithKline Company Details

Table 86. GlaxoSmithKline Business Overview

Table 87. GlaxoSmithKline Parkinson’s Disease Therapeutics Product

Table 88. GlaxoSmithKline Revenue in Parkinson’s Disease Therapeutics Business (2019-2024) & (US$ Million)

Table 89. GlaxoSmithKline Recent Developments

Table 90. H. Lundbeck A/S Company Details

Table 91. H. Lundbeck A/S Business Overview

Table 92. H. Lundbeck A/S Parkinson’s Disease Therapeutics Product

Table 93. H. Lundbeck A/S Revenue in Parkinson’s Disease Therapeutics Business (2019-2024) & (US$ Million)

Table 94. H. Lundbeck A/S Recent Developments

Table 95. Impax Labs Company Details

Table 96. Impax Labs Business Overview

Table 97. Impax Labs Parkinson’s Disease Therapeutics Product

Table 98. Impax Labs Revenue in Parkinson’s Disease Therapeutics Business (2019-2024) & (US$ Million)

Table 99. Impax Labs Recent Developments

Table 100. Newron Pharmaceuticals SpA Company Details

Table 101. Newron Pharmaceuticals SpA Business Overview

Table 102. Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Product

Table 103. Newron Pharmaceuticals SpA Revenue in Parkinson’s Disease Therapeutics Business (2019-2024) & (US$ Million)

Table 104. Newron Pharmaceuticals SpA Recent Developments

Table 105. Novartis AG Company Details

Table 106. Novartis AG Business Overview

Table 107. Novartis AG Parkinson’s Disease Therapeutics Product

Table 108. Novartis AG Revenue in Parkinson’s Disease Therapeutics Business (2019-2024) & (US$ Million)

Table 109. Novartis AG Recent Developments

Table 110. Orion Corporation Company Details

Table 111. Orion Corporation Business Overview

Table 112. Orion Corporation Parkinson’s Disease Therapeutics Product

Table 113. Orion Corporation Revenue in Parkinson’s Disease Therapeutics Business (2019-2024) & (US$ Million)

Table 114. Orion Corporation Recent Developments

Table 115. Teva Pharmaceutical Industries Ltd. Company Details

Table 116. Teva Pharmaceutical Industries Ltd. Business Overview

Table 117. Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Product

Table 118. Teva Pharmaceutical Industries Ltd. Revenue in Parkinson’s Disease Therapeutics Business (2019-2024) & (US$ Million)

Table 119. Teva Pharmaceutical Industries Ltd. Recent Developments

Table 120. UCB S.A. Company Details

Table 121. UCB S.A. Business Overview

Table 122. UCB S.A. Parkinson’s Disease Therapeutics Product

Table 123. UCB S.A. Revenue in Parkinson’s Disease Therapeutics Business (2019-2024) & (US$ Million)

Table 124. UCB S.A. Recent Developments

Table 125. Livzon Pharmaceutical Company Details

Table 126. Livzon Pharmaceutical Business Overview

Table 127. Livzon Pharmaceutical Parkinson’s Disease Therapeutics Product

Table 128. Livzon Pharmaceutical Revenue in Parkinson’s Disease Therapeutics Business (2019-2024) & (US$ Million)

Table 129. Livzon Pharmaceutical Recent Developments

Table 130. Haisco Pharmaceutical Company Details

Table 131. Haisco Pharmaceutical Business Overview

Table 132. Haisco Pharmaceutical Parkinson’s Disease Therapeutics Product

Table 133. Haisco Pharmaceutical Revenue in Parkinson’s Disease Therapeutics Business (2019-2024) & (US$ Million)

Table 134. Haisco Pharmaceutical Recent Developments

Table 135. Jingxin Pharmaceutical Company Details

Table 136. Jingxin Pharmaceutical Business Overview

Table 137. Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Product

Table 138. Jingxin Pharmaceutical Revenue in Parkinson’s Disease Therapeutics Business (2019-2024) & (US$ Million)

Table 139. Jingxin Pharmaceutical Recent Developments

Table 140. Dongcheng Biochemicals Company Details

Table 141. Dongcheng Biochemicals Business Overview

Table 142. Dongcheng Biochemicals Parkinson’s Disease Therapeutics Product

Table 143. Dongcheng Biochemicals Revenue in Parkinson’s Disease Therapeutics Business (2019-2024) & (US$ Million)

Table 144. Dongcheng Biochemicals Recent Developments

Table 145. Research Programs/Design for This Report

Table 146. Key Data Information from Secondary Sources

Table 147. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Parkinson’s Disease Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Parkinson’s Disease Therapeutics Market Share by Type: 2023 VS 2030

Figure 3. Oral Features

Figure 4. Transdermal Features

Figure 5. Subcutaneous Features

Figure 6. Intestinal Infusion Features

Figure 7. Global Parkinson’s Disease Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global Parkinson’s Disease Therapeutics Market Share by Application: 2023 VS 2030

Figure 9. Hospitals Case Studies

Figure 10. Clinics Case Studies

Figure 11. Others Case Studies

Figure 12. Parkinson’s Disease Therapeutics Report Years Considered

Figure 13. Global Parkinson’s Disease Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Parkinson’s Disease Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Parkinson’s Disease Therapeutics Market Share by Region: 2023 VS 2030

Figure 16. Global Parkinson’s Disease Therapeutics Market Share by Players in 2023

Figure 17. Global Top Parkinson’s Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson’s Disease Therapeutics as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Parkinson’s Disease Therapeutics Revenue in 2023

Figure 19. North America Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Parkinson’s Disease Therapeutics Market Share by Type (2019-2030)

Figure 21. North America Parkinson’s Disease Therapeutics Market Share by Application (2019-2030)

Figure 22. North America Parkinson’s Disease Therapeutics Market Share by Country (2019-2030)

Figure 23. United States Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Parkinson’s Disease Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 26. Europe Parkinson’s Disease Therapeutics Market Share by Type (2019-2030)

Figure 27. Europe Parkinson’s Disease Therapeutics Market Share by Application (2019-2030)

Figure 28. Europe Parkinson’s Disease Therapeutics Market Share by Country (2019-2030)

Figure 29. Germany Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. France Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. U.K. Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Italy Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Russia Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Nordic Countries Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. China Parkinson’s Disease Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 36. China Parkinson’s Disease Therapeutics Market Share by Type (2019-2030)

Figure 37. China Parkinson’s Disease Therapeutics Market Share by Application (2019-2030)

Figure 38. Asia Parkinson’s Disease Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 39. Asia Parkinson’s Disease Therapeutics Market Share by Type (2019-2030)

Figure 40. Asia Parkinson’s Disease Therapeutics Market Share by Application (2019-2030)

Figure 41. Asia Parkinson’s Disease Therapeutics Market Share by Region (2019-2030)

Figure 42. Japan Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. South Korea Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. China Taiwan Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Southeast Asia Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. India Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Australia Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Parkinson’s Disease Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Parkinson’s Disease Therapeutics Market Share by Type (2019-2030)

Figure 50. Middle East, Africa, and Latin America Parkinson’s Disease Therapeutics Market Share by Application (2019-2030)

Figure 51. Middle East, Africa, and Latin America Parkinson’s Disease Therapeutics Market Share by Country (2019-2030)

Figure 52. Brazil Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Mexico Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Turkey Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Saudi Arabia Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Israel Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. GCC Countries Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. Abbvie Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2019-2024)

Figure 59. Biogen Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2019-2024)

Figure 60. Boehringer Ingelheim GmbH Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2019-2024)

Figure 61. F. Hoffman-La Roche Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2019-2024)

Figure 62. GlaxoSmithKline Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2019-2024)

Figure 63. H. Lundbeck A/S Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2019-2024)

Figure 64. Impax Labs Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2019-2024)

Figure 65. Newron Pharmaceuticals SpA Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2019-2024)

Figure 66. Novartis AG Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2019-2024)

Figure 67. Orion Corporation Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2019-2024)

Figure 68. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2019-2024)

Figure 69. UCB S.A. Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2019-2024)

Figure 70. Livzon Pharmaceutical Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2019-2024)

Figure 71. Haisco Pharmaceutical Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2019-2024)

Figure 72. Jingxin Pharmaceutical Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2019-2024)

Figure 73. Dongcheng Biochemicals Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2019-2024)

Figure 74. Bottom-up and Top-down Approaches for This Report

Figure 75. Data Triangulation

Figure 76. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions